|
ADIPOR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.40080000043952E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.15669712591671E-11 |
| Normal-vs-Stage2 |
2.761400E-03 |
| Normal-vs-Stage3 |
3.221600E-01 |
| Normal-vs-Stage4 |
8.838000E-01 |
| Stage1-vs-Stage2 |
1.382390E-02 |
| Stage1-vs-Stage3 |
1.278650E-03 |
| Stage1-vs-Stage4 |
1.247430E-01 |
| Stage2-vs-Stage3 |
1.780420E-01 |
| Stage2-vs-Stage4 |
3.328800E-01 |
| Stage3-vs-Stage4 |
6.301600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25959999985881E-07 |
| Normal-vs-AfricanAmerican |
2.26419999999061E-05 |
| Normal-vs-Asian |
8.619700E-03 |
| Caucasian-vs-AfricanAmerican |
6.089400E-01 |
| Caucasian-vs-Asian |
9.183000E-01 |
| AfricanAmerican-vs-Asian |
7.576400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.69549995843977E-09 |
| Normal-vs-Female |
5.082000E-03 |
| Male-vs-Female |
1.259000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.006160E-02 |
| Normal-vs-Extreme_Weight |
1.98520089256249E-11 |
| Normal-vs-Obese |
1.984480E-04 |
| Normal-vs-Extreme_Obese |
2.217300E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.815600E-02 |
| Normal_Weight-vs-Obese |
6.398000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.449600E-01 |
| Extreme_Weight-vs-Obese |
3.513900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.359800E-01 |
| Obese-vs-Extreme_Obese |
4.120600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.320000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.90890999999249E-05 |
| Normal-vs-Age(61-80Yrs) |
6.10319994542863E-09 |
| Normal-vs-Age(81-100Yrs) |
1.47429999997062E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.510750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.118410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.818190E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.039600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.665520E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.561200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55899967882556E-10 |
| Normal-VS-Type2 PRCC |
1.680060E-03 |
| Normal-VS-KIRP CIMP |
1.623590E-01 |
| Normal-VS-Unclassified PRCC |
7.178800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.417100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.835800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.696210E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.923820E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.498600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.534240E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.02329999987994E-07 |
| Normal-vs-N1 |
6.561600E-01 |
| Normal-vs-N2 |
4.875800E-01 |
| N0-vs-N1 |
6.963000E-03 |
| N0-vs-N2 |
1.783400E-01 |
| N1-vs-N2 |
5.417600E-01 |
|
|
